[1]
Khan H, Reale M, Ullah H, et al. Anti-cancer effects of polyphenols via targeting p53 signaling pathway: Updates and future directions. Biotechnol Adv 2020; 38107385
[2]
Khan H, Mirzaei HR, Amiri A, Akkol EK, Haleemi SMA, Mirzaei H. Glyco-nanoparticles: New drug delivery systems in cancer therapy. Semin Cancer Biol 2019.
[http://dx.doi.org/10.1016/j.semcancer.2019.12.004]
[http://dx.doi.org/10.1016/j.semcancer.2019.12.004]
[3]
Khan H, Ullah H, Martorell M, et al. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Semin Cancer Biol 2019.
[http://dx.doi.org/10.1016/j.semcancer.2019.07.023]
[http://dx.doi.org/10.1016/j.semcancer.2019.07.023]
[4]
Rengasamy KRR, Khan H, Gowrishankar S, et al. The role of flavonoids in autoimmune diseases: Therapeutic updates. Pharmacol Ther 2019; 194: 107-31.
[5]
Khan H, Sureda A, Belwal T, et al. Polyphenols in the treatment of autoimmune diseases. Autoimmun Rev 2019; 18: 647-57.
[6]
Rengasamy KRR, Khan H, Ahmad I, et al. Bioactive peptides and proteins as alternative antiplatelet drugs. Med Res Rev 2019; 39: 2153-71.
[7]
Nabavi SF, Atanasov AG, Khan H, et al. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials. Cancer Lett 2018; 434: 101-13.